BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33123500)

  • 1. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.
    Narayan R; Tripathi S
    Front Cell Infect Microbiol; 2020; 10():580096. PubMed ID: 33123500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
    Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.
    Wang M; Yang F; Huang D; Huang Y; Zhang X; Wang C; Zhang S; Zhang R
    Front Cell Infect Microbiol; 2017; 7():157. PubMed ID: 28536674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.
    Shukla R; Ramasamy V; Shanmugam RK; Ahuja R; Khanna N
    Front Cell Infect Microbiol; 2020; 10():572681. PubMed ID: 33194810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection.
    Chotiwan N; Roehrig JT; Schlesinger JJ; Blair CD; Huang CY
    Virology; 2014 May; 456-457():238-46. PubMed ID: 24889243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
    Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
    PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.
    Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K
    PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.
    Chareonsirisuthigul T; Kalayanarooj S; Ubol S
    J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection.
    Callaway JB; Smith SA; McKinnon KP; de Silva AM; Crowe JE; Ting JP
    J Biol Chem; 2015 Jul; 290(28):17306-20. PubMed ID: 26032420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.
    Puerta-Guardo H; Mosso C; Medina F; Liprandi F; Ludert JE; del Angel RM
    J Gen Virol; 2010 Feb; 91(Pt 2):394-403. PubMed ID: 19828759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus: epidemiology, biology, and disease aetiology.
    Roy SK; Bhattacharjee S
    Can J Microbiol; 2021 Oct; 67(10):687-702. PubMed ID: 34171205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA
    J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Dambach KM; Donofrio GC; Tassaneetrithep B; Marovich MA
    J Virol; 2011 Feb; 85(4):1671-83. PubMed ID: 21123382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage.
    Martínez Gómez JM; Ong LC; Lam JH; Binte Aman SA; Libau EA; Lee PX; St John AL; Alonso S
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004536. PubMed ID: 27007501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.
    Moi ML; Lim CK; Kotaki A; Takasaki T; Kurane I
    J Virol Methods; 2010 Feb; 163(2):205-9. PubMed ID: 19781573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection.
    Wegman AD; Waldran MJ; Bahr LE; Lu JQ; Baxter KE; Thomas SJ; Waickman AT
    PLoS Pathog; 2023 Aug; 19(8):e1011616. PubMed ID: 37639455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.